Biography:
Tigör trained both in Germany and the US and earned his medical degree from Charité School of Medicine of Humboldt University, in Berlin, Germany. He spent several years in cardiovascular research including a research fellowship at Mount Sinai Hospital in New York, In 2019, he co-founded Auxilius Pharma, a Warsaw based biotech startup focusing on developing new, innovative treatment options for cardiovascular conditions with high unmet need such as chronic-stable angina.
Title : Current approaches to anti-angina drug treatment in Chronic-stable Angina Pectoris (CSAP) in US primary care and cardiology – A cross-sectional, blinded standard-of-care survey